Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shahin Ranjbar

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Iscience|December 6, 2019
Cytoplasmic RNA Sensor Pathways and Nitazoxanide Broadly Inhibit Intracellular Mycobacterium tuberculosis GrowthShahin Ranjbar, Viraga Haridas, Aya Nambu, et al.
Blood|April 16, 2005
Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIVSang-Kyung Lee, Derek M Dykxhoorn, Priti Kumar, et al.
Cell Reports|May 18, 2016
TREX1 Knockdown Induces an Interferon Response to HIV that Delays Viral Infection in Humanized MiceLee Adam Wheeler, Radiana T Trifonova, Vladimir Vrbanac, et al.
Iscience|August 13, 2019
The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola VirusLuke D Jasenosky, Cristhian Cadena, Chad E Mire, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine releaseCaroline Junqueira, Ângela Crespo, Shahin Ranjbar, et al.
Research Square|August 17, 2021
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine releaseCaroline Junqueira, Ângela Crespo, Shahin Ranjbar, et al.
Nature|April 6, 2022
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammationCaroline Junqueira, Ângela Crespo, Shahin Ranjbar, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamstersLisa Miorin, Chad E Mire, Shahin Ranjbar, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Iscience|December 6, 2019
Cytoplasmic RNA Sensor Pathways and Nitazoxanide Broadly Inhibit Intracellular Mycobacterium tuberculosis GrowthShahin Ranjbar, Viraga Haridas, Aya Nambu, et al.
Blood|April 16, 2005
Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIVSang-Kyung Lee, Derek M Dykxhoorn, Priti Kumar, et al.
Cell Reports|May 18, 2016
TREX1 Knockdown Induces an Interferon Response to HIV that Delays Viral Infection in Humanized MiceLee Adam Wheeler, Radiana T Trifonova, Vladimir Vrbanac, et al.
Iscience|August 13, 2019
The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola VirusLuke D Jasenosky, Cristhian Cadena, Chad E Mire, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine releaseCaroline Junqueira, Ângela Crespo, Shahin Ranjbar, et al.
Research Square|August 17, 2021
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine releaseCaroline Junqueira, Ângela Crespo, Shahin Ranjbar, et al.
Nature|April 6, 2022
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammationCaroline Junqueira, Ângela Crespo, Shahin Ranjbar, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamstersLisa Miorin, Chad E Mire, Shahin Ranjbar, et al.
Pageof 2